CN1756840A - 诱导体细胞同源重组的方法 - Google Patents
诱导体细胞同源重组的方法 Download PDFInfo
- Publication number
- CN1756840A CN1756840A CNA200380110005XA CN200380110005A CN1756840A CN 1756840 A CN1756840 A CN 1756840A CN A200380110005X A CNA200380110005X A CN A200380110005XA CN 200380110005 A CN200380110005 A CN 200380110005A CN 1756840 A CN1756840 A CN 1756840A
- Authority
- CN
- China
- Prior art keywords
- gene
- homologous recombination
- cell
- mentioned
- base sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006801 homologous recombination Effects 0.000 title claims abstract description 70
- 238000002744 homologous recombination Methods 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 58
- 230000001939 inductive effect Effects 0.000 title claims abstract description 35
- 210000001082 somatic cell Anatomy 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 144
- 210000004027 cell Anatomy 0.000 claims abstract description 67
- 230000035897 transcription Effects 0.000 claims abstract description 14
- 238000013518 transcription Methods 0.000 claims abstract description 14
- 230000002068 genetic effect Effects 0.000 claims abstract description 12
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 12
- 108010045262 enhanced cyan fluorescent protein Proteins 0.000 claims description 36
- 230000008521 reorganization Effects 0.000 claims description 15
- 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 claims description 14
- 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 claims description 14
- 210000000299 nuclear matrix Anatomy 0.000 claims description 14
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical group C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 claims description 13
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 11
- 230000033228 biological regulation Effects 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 29
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 7
- 230000005758 transcription activity Effects 0.000 abstract 1
- 239000013615 primer Substances 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 10
- 108091023040 Transcription factor Proteins 0.000 description 8
- 102000040945 Transcription factor Human genes 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229960003722 doxycycline Drugs 0.000 description 5
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 241000206602 Eukaryota Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008676 import Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 101150005709 ARG4 gene Proteins 0.000 description 2
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108010052160 Site-specific recombinase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- -1 enhanser Proteins 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 102000057593 human F8 Human genes 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
- 229940047431 recombinate Drugs 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- 101150058341 CFP gene Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
- 235000000434 Melocanna baccifera Nutrition 0.000 description 1
- 241001497770 Melocanna baccifera Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102100038567 Properdin Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101100004044 Vigna radiata var. radiata AUX22B gene Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 229950010131 puromycin Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002376555A JP5319863B2 (ja) | 2002-12-26 | 2002-12-26 | 体細胞相同組換えの誘発方法 |
JP376555/2002 | 2002-12-26 | ||
PCT/JP2003/016496 WO2004058964A1 (ja) | 2002-12-26 | 2003-12-22 | 体細胞相同組換えの誘発方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1756840A true CN1756840A (zh) | 2006-04-05 |
CN1756840B CN1756840B (zh) | 2010-08-04 |
Family
ID=32677367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200380110005XA Expired - Lifetime CN1756840B (zh) | 2002-12-26 | 2003-12-22 | 诱导体细胞同源重组的方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9587251B2 (zh) |
EP (1) | EP1584678B1 (zh) |
JP (1) | JP5319863B2 (zh) |
CN (1) | CN1756840B (zh) |
WO (1) | WO2004058964A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516637A (ja) | 2004-10-20 | 2008-05-22 | ザ スクリップス リサーチ インスティテュート | 真正細菌へのn−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み |
US20100291142A1 (en) * | 2007-10-18 | 2010-11-18 | Roger Maes | Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof |
JP6156144B2 (ja) | 2011-09-21 | 2017-07-05 | 富士レビオ株式会社 | 親和性複合体に対する抗体 |
-
2002
- 2002-12-26 JP JP2002376555A patent/JP5319863B2/ja not_active Expired - Lifetime
-
2003
- 2003-12-22 US US10/540,302 patent/US9587251B2/en not_active Expired - Lifetime
- 2003-12-22 EP EP03781013.2A patent/EP1584678B1/en not_active Expired - Lifetime
- 2003-12-22 WO PCT/JP2003/016496 patent/WO2004058964A1/ja active Application Filing
- 2003-12-22 CN CN200380110005XA patent/CN1756840B/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20060099678A1 (en) | 2006-05-11 |
US9587251B2 (en) | 2017-03-07 |
CN1756840B (zh) | 2010-08-04 |
JP2004201619A (ja) | 2004-07-22 |
WO2004058964A1 (ja) | 2004-07-15 |
EP1584678A1 (en) | 2005-10-12 |
JP5319863B2 (ja) | 2013-10-16 |
EP1584678A4 (en) | 2006-06-21 |
EP1584678B1 (en) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1182247C (zh) | 真核细胞中序列特异性dna重组 | |
CN1304578C (zh) | 新的基于蜕皮激素受体的可诱导的基因表达系统 | |
CN1468304A (zh) | 蛋白质功能域的制备方法 | |
CN1288244C (zh) | 信号序列捕获 | |
CN1612930A (zh) | 抑制基因表达的方法 | |
EA034039B1 (ru) | Клетка-хозяин, способная к сайт-специфической интеграции, способ ее получения и применение | |
CN1241211A (zh) | 体内重组 | |
CN1484707A (zh) | 修饰真核细胞的方法 | |
CN109750035B (zh) | 靶向并引导Cas9蛋白高效切割TCR及B2M基因座的sgRNA | |
CN1141059A (zh) | P53-结合多肽和编码该多肽的多核苷酸 | |
CN1671842A (zh) | 增强体细胞同源重组的方法和构建特异抗体的方法 | |
CN1437476A (zh) | 优化的小基因及其编码的肽 | |
CN1262668C (zh) | 转移核酸通过核被膜的细胞转运系统的用途 | |
CN1934244A (zh) | 在基因转变活跃的细胞中实现遗传多样化的方法 | |
CN1756840A (zh) | 诱导体细胞同源重组的方法 | |
CN107012168A (zh) | 人工染色体载体 | |
CN113748205A (zh) | 用于改进的基因编辑的组合物和方法 | |
CN1602359A (zh) | 靶向性载体的制备方法及其应用 | |
CN108034674B (zh) | 一种快速建立基因敲除细胞株的重组载体及其方法 | |
CN100336906C (zh) | 脂肪酶基因序列及其在酵母中的应用 | |
WO2021197342A1 (en) | Active dna transposon systems and methods for use thereof | |
CN1795205A (zh) | Spex组合物和使用方法 | |
CN104975018B (zh) | 一种新型增强子及其应用 | |
CN100335632C (zh) | 牦牛的七种乳蛋白基因序列 | |
Xie et al. | Precise genome editing of the Kozak sequence enables bidirectional and quantitative modulation of protein translation to anticipated levels without affecting transcription |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KAIAOMU BIOSCIENCE CO., LTD. Free format text: FORMER OWNER: JAPAN SCIENCE AND TECHNOLOGY AGENCY |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20101111 Address after: Saitama Prefecture of Japan and the city of light Co-patentee after: CHIOME BIOSCIENCE Inc. Patentee after: RIKEN Address before: Saitama Prefecture of Japan and the city of light Co-patentee before: JAPAN SCIENCE AND TECHNOLOGY AGENCY Patentee before: RIKEN |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20100804 |